GPhA, BIO compromise on interchangeability

The Generic Pharmaceutical Association (GPhA) and the Biotechnology Industry Organization (BIO) have agreed to introduce the same proposal to state legislatures

Read the full 217 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE